http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006329643-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d041a1464f9d69913492c2b148a2da81 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc32a119ff62b76264dd4339f28b4db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0d704c5a9bfcef04d50cba0ce9a4ef7 |
| publicationDate | 2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006329643-A |
| titleOfInvention | Antithrombotic drug efficacy test method |
| abstract | 【Task】 When a platelet activity activator is responsible for promoting blood coagulation, it is intended to provide a method for quickly and easily testing how an antithrombotic drug inhibits the promotion of blood coagulation. [Solution] A system in which an anticoagulant is added to a part of blood collected from a patient receiving antithrombotic drugs (system X blood), and an anticoagulant and adenosine diphosphate or collagen are added to a part of the blood This is a test method for determining the efficacy of an antithrombotic drug by simultaneously measuring the thromboelastograph for the system (Y system blood) and comparing the R values of the X system blood and the Y system blood. If the R value of the Y blood does not significantly differ from the R value of the X blood, it is determined that the medicinal effect is functioning. As the anticoagulant, adenosine diphosphate or collagen can be used. The present invention provides a method for easily determining the efficacy of an antithrombotic drug that has not been conventionally known. [Selection] FIG. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014098056-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009028047-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014098056-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10266871-B2 |
| priorityDate | 2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.